After hours
⌘K
Sign in Sign up
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Braveheart Bio, Inc.

BRVE
Transactions reported in official disclosures

34 trades

Reporting person Filed Transaction Transaction value Source
Ah Bio Fund Iv, L.p. 10% owner Aug 11, 2026 4-day lag Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Ah Bio Fund Iv, L.p. 10% owner Aug 11, 2026 4-day lag Conversion Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Ah Bio Fund Iv, L.p. 10% owner Aug 11, 2026 4-day lag Buy Aug 7, 2026 $19.8M Filed shares x price SEC Form 4 View filing
Chimovits Erez Director / Ten Percent Owner Aug 11, 2026 4-day lag Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Chimovits Erez Director / Ten Percent Owner Aug 11, 2026 4-day lag Buy Aug 7, 2026 $4.92M Filed shares x price SEC Form 4 View filing
Chimovits Erez Director / Ten Percent Owner Aug 11, 2026 4-day lag Buy Aug 7, 2026 $30M Filed shares x price SEC Form 4 View filing
Chimovits Erez Director / Ten Percent Owner Aug 11, 2026 4-day lag Conversion Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Orbimed Advisors Llc Director / Ten Percent Owner Aug 11, 2026 4-day lag Buy Aug 7, 2026 $4.92M Filed shares x price SEC Form 4 View filing
Orbimed Advisors Llc Director / Ten Percent Owner Aug 11, 2026 4-day lag Conversion Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Orbimed Advisors Llc Director / Ten Percent Owner Aug 11, 2026 4-day lag Buy Aug 7, 2026 $30M Filed shares x price SEC Form 4 View filing
Orbimed Advisors Llc Director / Ten Percent Owner Aug 11, 2026 4-day lag Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Jiangsu Hengrui Pharmaceuti... 10% owner Aug 10, 2026 3-day lag Conversion Aug 7, 2026 Not reported Reported range SEC Form 4 View filing
Jiangsu Hengrui Pharmaceuti... 10% owner Aug 10, 2026 3-day lag Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Forbion Growth Opportunitie... 10% owner Aug 7, 2026 Same-day filing Buy Aug 7, 2026 $30.24M Filed shares x price SEC Form 4 View filing
Forbion Growth Opportunitie... 10% owner Aug 7, 2026 Same-day filing Buy Aug 7, 2026 $34.56M Filed shares x price SEC Form 4 View filing
Forbion Growth Opportunitie... 10% owner Aug 7, 2026 Same-day filing Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Forbion Growth Opportunitie... 10% owner Aug 7, 2026 Same-day filing Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Forbion Growth Opportunitie... 10% owner Aug 7, 2026 Same-day filing Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Forbion Growth Opportunitie... 10% owner Aug 7, 2026 Same-day filing Conversion Aug 7, 2026 $0 Filed shares x price SEC Form 4 View filing
Rickey James Paul Chief Financial Officer Aug 7, 2026 Same-day filing Buy Aug 7, 2026 $499.99K Filed shares x price SEC Form 4 View filing
Rickey James Paul Chief Financial Officer Aug 7, 2026 2-day lag Award Aug 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Lohoff Tim Director Aug 7, 2026 2-day lag Award Aug 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Chimovits Erez Director / Ten Percent Owner Aug 7, 2026 2-day lag Award Aug 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Viehbacher Christopher Director Aug 7, 2026 Same-day filing Buy Aug 7, 2026 $1.5M Filed shares x price SEC Form 4 View filing
Viehbacher Christopher Director Aug 7, 2026 2-day lag Award Aug 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Malek David I Director Aug 7, 2026 Same-day filing Buy Aug 7, 2026 $74.99K Filed shares x price SEC Form 4 View filing
Malek David I Director Aug 7, 2026 2-day lag Award Aug 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Anderson Michele A. Chief Development Officer Aug 7, 2026 Same-day filing Buy Aug 7, 2026 $20K Filed shares x price SEC Form 4 View filing
Anderson Michele A. Chief Development Officer Aug 7, 2026 2-day lag Award Aug 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Murdoch Travis CEO And President Aug 7, 2026 Same-day filing Buy Aug 7, 2026 $1.5M Filed shares x price SEC Form 4 View filing
Ah Bio Fund Iv, L.p. 10% owner
Conversion
Calculated transaction value
$0 40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Ah Bio Fund Iv, L.p. 10% owner
Conversion
Reported value range
Not reported 9,132,420 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Ah Bio Fund Iv, L.p. 10% owner
Buy
Calculated transaction value
$19.8M 1,100,000 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Chimovits Erez Director / Ten Percent Owner
Conversion
Calculated transaction value
$0 40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Chimovits Erez Director / Ten Percent Owner
Buy
Calculated transaction value
$4.92M 273,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Chimovits Erez Director / Ten Percent Owner
Buy
Calculated transaction value
$30M 1,666,667 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Chimovits Erez Director / Ten Percent Owner
Conversion
Reported value range
Not reported 9,132,420 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Orbimed Advisors Llc Director / Ten Percent Owner
Buy
Calculated transaction value
$4.92M 273,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Orbimed Advisors Llc Director / Ten Percent Owner
Conversion
Reported value range
Not reported 9,132,420 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Orbimed Advisors Llc Director / Ten Percent Owner
Buy
Calculated transaction value
$30M 1,666,667 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Orbimed Advisors Llc Director / Ten Percent Owner
Conversion
Calculated transaction value
$0 40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 11, 2026
SEC Form 4
View filing Trade details
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner
Conversion
Reported value range
Not reported 7,420,091 shares
Traded
Aug 7, 2026
Filed
Aug 10, 2026
SEC Form 4
View filing Trade details
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner
Conversion
Calculated transaction value
$0 32,500,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 10, 2026
SEC Form 4
View filing Trade details
Forbion Growth Opportunities Fund Iii Cooperatief U.a. 10% owner
Buy
Calculated transaction value
$30.24M 1,680,000 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Forbion Growth Opportunities Fund Iii Cooperatief U.a. 10% owner
Buy
Calculated transaction value
$34.56M 1,920,000 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Forbion Growth Opportunities Fund Iii Cooperatief U.a. 10% owner
Conversion
Calculated transaction value
$0 9,132,420 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Forbion Growth Opportunities Fund Iii Cooperatief U.a. 10% owner
Conversion
Calculated transaction value
$0 35,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Forbion Growth Opportunities Fund Iii Cooperatief U.a. 10% owner
Conversion
Calculated transaction value
$0 40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Forbion Growth Opportunities Fund Iii Cooperatief U.a. 10% owner
Conversion
Calculated transaction value
$0 7,990,867 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Rickey James Paul Chief Financial Officer
Buy
Calculated transaction value
$499.99K 27,777 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Rickey James Paul Chief Financial Officer
Award
Calculated transaction value
$0 300,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Lohoff Tim Director
Award
Calculated transaction value
$0 30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Chimovits Erez Director / Ten Percent Owner
Award
Calculated transaction value
$0 30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Viehbacher Christopher Director
Buy
Calculated transaction value
$1.5M 83,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Viehbacher Christopher Director
Award
Calculated transaction value
$0 30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Malek David I Director
Buy
Calculated transaction value
$74.99K 4,166 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Malek David I Director
Award
Calculated transaction value
$0 30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Anderson Michele A. Chief Development Officer
Buy
Calculated transaction value
$20K 1,111 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Anderson Michele A. Chief Development Officer
Award
Calculated transaction value
$0 300,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details
Murdoch Travis CEO And President
Buy
Calculated transaction value
$1.5M 83,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
SEC Form 4
View filing Trade details

Showing 1 to 30 of 34 entries